As it stated in prnewswire
Global Cell Therapy Technologies Markets and Companies Analysis 2015-2025
Global Cell Therapy Technologies Markets and Companies Analysis 2015-2025
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants.Role of cells in drug discovery is also described.
moreover from investors
Novartis Closing Cell Therapy Unit; CAR-T Stocks Tumble
Novartis Closing Cell Therapy Unit; CAR-T Stocks Tumble
Swiss pharma giant Novartis (NVS) said Wednesday that it's shuttering its Cell & Gene Therapy unit, though it said it remains committed to its cancer-fighting CAR-T cell program.The market took this as a negative vote for the program, however, knocking down CAR-T-focused stocks Juno Therapeutics (JUNO), Bluebird Bio (BLUE) and Kite Pharma (KITE).The website Endpoint News first reported the Cell & Gene Therapy Unit's disbanding, saying that its activities will be integrated into the larger Novartis organization, but about 120 of the 400 positions there will be eliminated, including unit head Usman Azam.
by the same token on medgadget
Global Stem Cell Therapy Market To Witness Rapid Growth As Focus On Human Embryonic Stem Cells Grows
Global Stem Cell Therapy Market To Witness Rapid Growth As Focus On Human Embryonic Stem Cells Grows
MarketResearchReports.biz has recently announced the inclusion of a new market intelligence study to its vast repository of research reports.The 248-page research study, titled "PharmaSphere: Emerging Biotechnologies – Stem Cell Therapy," offers a detailed analysis of the market, throwing light on the key opportunities and trends in the overall market.The key growth drivers, challenges, product segmentation, vendor analysis, and key geographical segments of the global market for stem cell therapy have been discussed in the scope of the research report.
No comments:
Post a Comment